Summit Securities Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-9,000
Closed -$314K – 1156
2022
Q1
$314K Buy
+9,000
New +$308K 0.04% 301

Other funds holding OGN

Summit Securities Group's OGN Position: Q3 2026 in Review

Summit Securities Group opened a new position in Organon & Co (OGN) in Q3 2026: 30,170 shares worth $413K. The stake represents 0.04% of the portfolio and ranks #211 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in OGN as recently as Q4 2025.

Summit Securities Group first reported a position in OGN in Q1 2022 and has held it in 15 quarters since. The position peaked at $451K in Q2 2024. 607 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Summit Securities Group held 30,170 shares of Organon & Co worth $413K as of Q3 2026.
  • Organon & Co was a new Summit Securities Group position in Q3 2026.
  • Organon & Co made up 0.04% of Summit Securities Group's portfolio in Q3 2026, its #211 holding.
  • Summit Securities Group first reported a position in Organon & Co in Q1 2022 and has held it in 15 quarters since.
  • Summit Securities Group's Organon & Co position peaked at $451K in Q2 2024.
  • 607 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.